Fidelity Investments
BNGO icon

Fidelity Investments’s Bionano Genomics BNGO Stock Holding History

Fidelity Investments’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$7 – 5583
2026
Q1 		$7 Buy
+6
New +$8 ﹤0.01% 5382
2025
Q2 		– Sell
-2
Closed -$6 – 5338
2025
Q1 		$6 Sell
2
-5
-71% -$33 ﹤0.01% 5257
2024
Q4 		$118 Sell
7
-6
-46% -$103 ﹤0.01% 5088
2024
Q3 		$351 Sell
13
-30
-70% -$933 ﹤0.01% 5000
2024
Q2 		$1.77K Sell
43
-11
-20% -$605 ﹤0.01% 4744
2024
Q1 		$3.6K Sell
54
-839
-94% -$62.6K ﹤0.01% 4594
2023
Q4 		$101K Buy
893
+533
+148% +$55.7K ﹤0.01% 3212
2023
Q3 		$65.5K Buy
360
+353
+5,043% +$92.5K ﹤0.01% 3263
2023
Q2 		$2.74K Sell
7
-3
-30% -$1.35K ﹤0.01% 4517
2023
Q1 		$6.58K Sell
10
-23
-70% -$20.4K ﹤0.01% 4292
2022
Q4 		$29.1K Sell
33
-85
-72% -$107K ﹤0.01% 3644
2022
Q3 		$130K Sell
118
-31
-21% -$41K ﹤0.01% 3186
2022
Q2 		$123K Sell
149
-31
-17% -$31.9K ﹤0.01% 3257
2022
Q1 		$278K Buy
+180
New +$243K ﹤0.01% 3169
2021
Q4 		– Hold
0
– – – 4354
2021
Q3 		– Hold
0
– – – 4362
2021
Q2 		– Hold
0
– – – 4259
2021
Q1 		– Hold
0
– – – 3990

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Fidelity Investments's BNGO Position: Q2 2026 in Review

Fidelity Investments sold out of Bionano Genomics (BNGO) in Q2 2026, closing a stake of 6 shares — an estimated $7 sold.

Fidelity Investments first reported a position in BNGO in Q1 2022 and held it in 14 quarters. The position peaked at $278K in Q1 2022. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Fidelity Investments reported no remaining Bionano Genomics position as of Q2 2026 after selling out during the quarter.
  • Fidelity Investments sold 6 Bionano Genomics shares in Q2 2026, an estimated $7.
  • Fidelity Investments first reported a position in Bionano Genomics in Q1 2022 and held it in 14 quarters.
  • Fidelity Investments's Bionano Genomics position peaked at $278K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.